Johnson & Johnson
Foreign stocks · NYSE · Healthcare · Pharmaceuticals and medical devices
A healthcare company with two businesses: innovative medicines (cancer, immunology and psychiatric drugs) and medical devices (surgical, cardiac, orthopaedic and eye lenses)
For every 100 dollars of sales: cost of sales 32 · operating expenses 41 · other income after tax adds 2 · leaving 28 as net profit
Investors in Thailand can buy JNJ through 49 mutual funds open to retail investors. Most of them (49 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds JNJ.
| Fund | JNJ weight | How it invests | 1-year return |
|---|---|---|---|
 TUSHEALTH-ATISCO US Healthcare Fund | 10.28% | Via XLV | +26.16% |
 LHHEALTH-A |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
| Master fund | Thai funds using this route | Master fund's JNJ weight |
|---|---|---|
| Janus Henderson Global Life Sciences Fund | 7 | 7.87% |
| GMO Quality Investment Fund | 4 | 4.11% |
| JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | 3 | 6.43% |
| JPMorgan Funds - Global Healthcare Fund | 3 | 6.28% |
| 9.43% |
| Via AB International Health Care Portfolio |
| +21.99% |
 MHEALTHGMFC Health Innovation Fund | 8.78% | Via BGF World Healthscience Fund | +18.39% |
| MHEALTHRMFMFC Health Innovation Retirement Fund | 8.59% | Via BGF World Healthscience Fund | +19.08% |
 SCBGHCSCB GLOBAL HEALTH CARE EQUITY FUND | 7.87% | Via Janus Henderson Global Life Sciences Fund | +19.93% |
| SCBRMGHCSCB GLOBAL HEALTH CARE RMF | 7.85% | Via Janus Henderson Global Life Sciences Fund | +19.99% |
 KT-HEALTHCARE-AKTAM World Healthcare Fund | 7.75% | Via Janus Henderson Global Life Sciences Fund | +23.93% |
| KT-HEALTHC RMFKTAM World Healthcare RMF | 7.70% | Via Janus Henderson Global Life Sciences Fund | +23.64% |
 KKP GHC-AKKP GLOBAL HEALTH CARE FUND | 7.70% | Via Janus Henderson Global Life Sciences Fund | +19.77% |
 ES-HEALTHCARERMFEastspring Global Healthcare RMF | 7.59% | Via Janus Henderson Global Life Sciences Fund | +22.51% |
Yearly average over the last 4 years · Latest annual sales 94.2B USD
For every 100 dollars of sales, about 28 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now close to its 1-year high
| Item (USD) | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 78.7B USD | 80.0B USD | 85.2B USD | 88.8B USD | 94.2B USD |
| Gross profit | 55.3B USD | 55.4B USD | 58.6B USD | 61.4B USD | 63.9B USD |
| Net profit |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 271.15 | 271.17 | Above |
| 20 days | 264.33 | 267.62 | Above |
| 50 days | 265.73 | 264.53 | Above |
| 100 days | 261.29 | 258.97 | Above |
| 200 days |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 63.46 | Up |
| MACD(12,26) | 3.50 | Up |
| ADX(14) | 22.33 | Neutral |
| ATR(14) % of price | 1.39 | Neutral |
KASSET
KSAM8MFC5TISCOASSET4LHFUND4KTAM4EASTSPRING3
UOBAM3| Fund | JNJ weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| TUSHEALTH-A | 10.28% | XLV | +26.16% | 1.31% |
| LHHEALTH-A | 9.43% | AB International Health Care Portfolio | +21.99% | 2.16% |
| MHEALTHG | 8.78% | BGF World Healthscience Fund | +18.39% | 2.00% |
| MHEALTHRMF | 8.59% | BGF World Healthscience Fund | +19.08% | 1.81% |
| SCBGHC | 7.87% | Janus Henderson Global Life Sciences Fund | +19.93% | 1.72% |
| SCBRMGHC | 7.85% | Janus Henderson Global Life Sciences Fund | +19.99% | 1.18% |
| KT-HEALTHCARE-A | 7.75% | Janus Henderson Global Life Sciences Fund | +23.93% | 1.34% |
| KT-HEALTHC RMF | 7.70% | Janus Henderson Global Life Sciences Fund | +23.64% | 1.97% |
| KKP GHC-A | 7.70% | Janus Henderson Global Life Sciences Fund | +19.77% | 1.21% |
| ES-HEALTHCARERMF | 7.59% | Janus Henderson Global Life Sciences Fund | +22.51% | 1.78% |
| ES-HEALTHCARE | 7.58% | Janus Henderson Global Life Sciences Fund | +23.39% | 1.24% |
 FP HCARE-A | 7.53% | Manulife Global Fund – Healthcare Fund | +27.36% | 2.19% |
| TGHRMF-A | 6.99% | several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | +23.95% | 1.60% |
| K-GHEALTH | 6.43% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +17.85% | 1.75% |
| K-GHRMF | 6.43% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +18.01% | 1.74% |
| KFHHCARE-A | 6.28% | JPMorgan Funds - Global Healthcare Fund | +16.68% | 1.54% |
| KFHCARERMF | 6.26% | JPMorgan Funds - Global Healthcare Fund | +17.28% | 1.54% |
| KFHEALTH-A | 6.24% | JPMorgan Funds - Global Healthcare Fund | +24.48% | 1.53% |
| K-GHEALTH(UH) | 6.10% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +23.58% | 1.76% |
| TGHSTARP | 5.32% | several master funds (BlackRock Global Funds - World Healthscience) | +16.21% | 1.90% |
| Fund | JNJ weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| UHCRMF | 5.02% | United Global Healthcare Fund | +18.13% | 1.86% |
| UGH | 4.98% | United Global Healthcare Fund | +18.22% | 1.88% |
| UOBSHC | 4.98% | United Global Healthcare Fund | +18.37% | 1.86% |
 BCARERMF | 4.77% | Wellington Global Health Care Equity Fund | +23.29% | 1.48% |
| BCARE | 4.76% | Wellington Global Health Care Equity Fund | +23.67% | 1.24% |
| BCARESSF | 4.74% | Wellington Global Health Care Equity Fund | +23.45% | 1.23% |
| KF-SP500M | 4.49% | SPMO | N/A | 1.00% |
| KF-SP500MFX | 4.40% | SPMO | N/A | 1.00% |
| LHGEQRMF | 4.11% | GMO Quality Investment Fund | +12.82% | 2.47% |
 DAOL-GEQUITY | 4.09% | GMO Quality Investment Fund | +12.06% | 2.28% |
| LHGEQ-A | 4.08% | GMO Quality Investment Fund | +12.71% | 2.34% |
| DAOL-GLOBALEQRMF | 4.07% | GMO Quality Investment Fund | +12.41% | 2.53% |
| LHUS-A | 3.40% | several master funds | −26.49% | 1.90% |
| K-GSELECTRMF | 2.64% | JGLO | +4.12% | 1.73% |
| K-GSELECT | 2.64% | JGLO | +3.82% | 1.47% |
| K-GSELECTU-A(A) | 2.52% | JGLO | +10.21% | 1.43% |
| ES-LOVE | 2.50% | Eastspring Investments – Global Low Volatility Equity Fund | +12.65% | 1.26% |
| KT-WISLAMIC-A | 2.38% | ISDW | +17.25% | 0.90% |
| KFESG-A | 2.37% | AB Sustainable Global Thematic Portfolio | −4.01% | 1.54% |
| KFESGRMF | 2.37% | AB Sustainable Global Thematic Portfolio | −4.15% | 1.59% |
| KFESGSSF | 2.35% | AB Sustainable Global Thematic Portfolio | −4.16% | 1.68% |
| K-GPIN-A(A) | 2.05% | JEPG | +8.95% | 1.14% |
| K-GPINUH-A(A) | 1.97% | JEPG | +15.04% | 0.95% |
| M-JEPI-H-AC | 1.90% | JEPI | +6.93% | 1.16% |
| M-JEPI-UH-AC | 1.87% | JEPI | +13.76% | 1.15% |
| MGMVOL | 1.52% | ACWV | +10.15% | 0.91% |
| TGHIDIV | 1.48% | several master funds (JPMorgan Investment Funds - Global Dividend, DWS Invest Top Dividend) | +5.48% | 1.85% |
 TLQUANT-GROW-A | 1.32% | several master funds | N/A | 1.80% |
| KT-IGF-A | 0.90% | Allianz Income and Growth | +0.67% | 1.28% |
| United Global Healthcare Fund |
| 3 |
| 5.02% |
| Wellington Global Health Care Equity Fund | 3 | 4.77% |
| JPMorgan Global Select Equity ETF | 3 | 2.64% |
| AB Sustainable Global Thematic Portfolio | 3 | 2.37% |
| BGF World Healthscience Fund | 2 | 8.78% |
| Invesco S&P 500® Momentum ETF | 2 | 4.49% |
| several master funds | 2 | 3.40% |
| JPMorgan ETFs (Ireland) ICAV - Global Equity Premium Income Active UCITS ETF - USD (dist) | 2 | 2.05% |
| JPMorgan ETFs (Ireland) ICAV - US Equity Premium Income Active UCITS ETF | 2 | 1.90% |
| State Street Health Care Select Sector SPDR ETF | 1 | 10.28% |
| AB International Health Care Portfolio | 1 | 9.43% |
| 20.9B USD |
| 17.9B USD |
| 35.2B USD |
| 14.1B USD |
| 26.8B USD |
| EPS (diluted) | 7.81 | 6.73 | 13.72 | 5.79 | 11.03 |
| Gross margin | 70.3% | 69.3% | 68.8% | 69.1% | 67.9% |
| Net margin | 26.5% | 22.4% | 41.3% | 15.8% | 28.5% |
| Operating cash flow | 23.4B USD | 21.2B USD | 22.8B USD | 24.3B USD | 24.5B USD |
| Free cash flow | 19.8B USD | 17.2B USD | 18.2B USD | 19.8B USD | 19.7B USD |
| Total assets | 182.0B USD | 187.4B USD | 167.6B USD | 180.1B USD | 199.2B USD |
| Total liabilities | 108.0B USD | 110.6B USD | 98.8B USD | 108.6B USD | 117.7B USD |
| Shareholders' equity | 74.0B USD | 76.8B USD | 68.8B USD | 71.5B USD | 81.5B USD |
| 248.08 |
| 245.41 |
| Above |
